Back
Park Aerospace 10K Form
Buy
52
PKE
Park Aerospace
Last Price:
13.44
Seasonality Move:
10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-01-10 | 10Q | PKE/Park Aerospace Quarterly |
2023-10-06 | 10Q | PKE/Park Aerospace Quarterly |
2023-07-07 | 10Q | PKE/Park Aerospace Quarterly |
2023-01-06 | 10Q | PKE/Park Aerospace Quarterly |
2022-10-07 | 10Q | PKE/Park Aerospace Quarterly |
2022-07-08 | 10Q | PKE/Park Aerospace Quarterly |
Receive PKE News And Ratings
See the #1 stock for the next 7 days that we like better than PKE
PKE Financial Statistics
Sales & Book Value
Annual Sales: | $56M |
---|---|
Cash Flow: | $1.25M |
Price / Cash Flow: | 36.01 |
Annual Sales: | $5.44 |
Price / Book: | 2.44 |
Profitability
EPS (TTM): | 0.34000 |
---|---|
Net Income (TTM): | $6.93M |
Gross Margin: | $16.53M |
Return on Equity: | 6.19% |
Return on Assets: | 5.39% |
Park Aerospace Earnings Forecast
Key Park Aerospace Financial Ratios
- The Gross Profit Margin over the past 41 years for PKE is 29.52%.
- The Selling, General & Administrative Expenses for PKE have been equal to 14.56% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of PKE is 13.34% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 20 years.
Park Aerospace Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | PKE |
CUSIP: | 700416 |
Website: | parkaerospace.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 9.11 |
Quick Ratio: | 8.12 |
Price-to-Earnings
Trailing P/E Ratio: | 36.35 |
---|---|
Forward P/E Ratio: | 0 |
PKE Technical Analysis vs Fundamental Analysis
Buy
52
Park Aerospace (PKE)
is a Buy
Is Park Aerospace a Buy or a Sell?
-
Park Aerospace stock is rated a Buy
The current Park Aerospace [PKE] share price is $13.45. The Score for PKE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.